These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

937 related items for PubMed ID: 23279894

  • 1. Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.
    McKimm-Breschkin JL.
    Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):25-36. PubMed ID: 23279894
    [Abstract] [Full Text] [Related]

  • 2. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C, Kondo H, Dapat IC, Baranovich T, Suzuki Y, Shobugawa Y, Saito K, Saito R, Suzuki H.
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [Abstract] [Full Text] [Related]

  • 3. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
    Okomo-Adhiambo M, Sleeman K, Lysén C, Nguyen HT, Xu X, Li Y, Klimov AI, Gubareva LV.
    Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
    [Abstract] [Full Text] [Related]

  • 4. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
    Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC, Tashiro M.
    Antiviral Res; 2015 May; 117():27-38. PubMed ID: 25721488
    [Abstract] [Full Text] [Related]

  • 5. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
    Baek YH, Song MS, Lee EY, Kim YI, Kim EH, Park SJ, Park KJ, Kwon HI, Pascua PN, Lim GJ, Kim S, Yoon SW, Kim MH, Webby RJ, Choi YK.
    J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
    [Abstract] [Full Text] [Related]

  • 6. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
    Gubareva LV, Besselaar TG, Daniels RS, Fry A, Gregory V, Huang W, Hurt AC, Jorquera PA, Lackenby A, Leang SK, Lo J, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Odagiri T, Wang D, Zhang W, Meijer A.
    Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
    [Abstract] [Full Text] [Related]

  • 7. In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018-19 season: Comparison with the 2010-11 to 2017-18 seasons.
    Ikematsu H, Kawai N, Tani N, Chong Y, Bando T, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2020 Aug; 26(8):775-779. PubMed ID: 32249161
    [Abstract] [Full Text] [Related]

  • 8. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ, Choi WS, Jeong JH, Kim EH, Lee OJ, Yoon SW, Hwang J, Webby RJ, Govorkova EA, Choi YK, Baek YH, Song MS.
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [Abstract] [Full Text] [Related]

  • 9. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
    Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
    [Abstract] [Full Text] [Related]

  • 10. In Vitro and In Vivo Characterization of Novel Neuraminidase Substitutions in Influenza A(H1N1)pdm09 Virus Identified Using Laninamivir-Mediated In Vitro Selection.
    Lloren KKS, Kwon JJ, Choi WS, Jeong JH, Ahn SJ, Choi YK, Baek YH, Song MS.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30602610
    [Abstract] [Full Text] [Related]

  • 11. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H, Kawai N, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2015 Sep 15; 21(9):634-8. PubMed ID: 26096495
    [Abstract] [Full Text] [Related]

  • 12. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV.
    Antiviral Res; 2010 Feb 15; 85(2):381-8. PubMed ID: 19917319
    [Abstract] [Full Text] [Related]

  • 13. Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.
    Franco-May DA, Gómez-Carballo J, Barrera-Badillo G, Cruz-Ortíz MN, Núñez-García TE, Arellano-Suárez DS, Wong-Arámbula C, López-Martínez I, Wong-Chew RM, Ayora-Talavera G.
    Antiviral Res; 2024 Jul 15; 227():105918. PubMed ID: 38795911
    [Abstract] [Full Text] [Related]

  • 14. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
    Hurt AC, Holien JK, Parker MW, Barr IG.
    Drugs; 2009 Jul 15; 69(18):2523-31. PubMed ID: 19943705
    [Abstract] [Full Text] [Related]

  • 15. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI.
    Antivir Ther; 2010 Jul 15; 15(8):1151-9. PubMed ID: 21149922
    [Abstract] [Full Text] [Related]

  • 16. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
    Abed Y, Baz M, Boivin G.
    Antivir Ther; 2006 Jul 15; 11(8):971-6. PubMed ID: 17302366
    [Abstract] [Full Text] [Related]

  • 17. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
    L'Huillier AG, Abed Y, Petty TJ, Cordey S, Thomas Y, Bouhy X, Schibler M, Simon A, Chalandon Y, van Delden C, Zdobnov E, Boquete-Suter P, Boivin G, Kaiser L.
    J Infect Dis; 2015 Dec 01; 212(11):1726-34. PubMed ID: 25985905
    [Abstract] [Full Text] [Related]

  • 18. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H.
    J Infect Chemother; 2012 Dec 01; 18(6):858-64. PubMed ID: 22644080
    [Abstract] [Full Text] [Related]

  • 19. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H, Kawai N, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2015 Jan 01; 21(1):39-42. PubMed ID: 25277670
    [Abstract] [Full Text] [Related]

  • 20. Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.
    Tewawong N, Vichiwattana P, Korkong S, Klinfueng S, Suntronwong N, Thongmee T, Theamboonlers A, Vongpunsawad S, Poovorawan Y.
    PLoS One; 2017 Jan 01; 12(4):e0175655. PubMed ID: 28410396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.